Thalidomide and Lenalidomide for Refractory SLE/CLE Thalidomide and Lenalidomide for Refractory SLE/CLE

What do we currently know about the safety and efficacy of these drug options for the treatment of refractory systemic/cutaneous lupus erythematosus?Journal of Clinical Rheumatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news